Taurine Benefits - are they real or hype?

Supplements
#166

So what is the appropriate dose and does it vary by age and gender? I just increased morning Taurine from 2 to 3 grams, wondering if I should go to 4 – or higher?

1 Like
#167

From what I know, people take from 1 to 6g.

I chose 6g based on being vegan and knowing I was probably deficient… and hoping it would give me Agetron bone results… which it didn’t.

4 Likes
#168

Your bone scan results intrigue me.
I have also been taking a teaspoon of taurine in my coffee every morning for about 3 years. Never had a bone scan before, though. I need to book one in to see what’s going on.

1 Like
#169

Yes…I’d say its about 15 grams.
So cheap… why not go with a big dose

1 Like
#170

Ahhhhh, so when you say teaspoon, you don’t mean an actual tsp… you mean silverware tsp… I was wondering why you were taking such a tiny dose…. 1/2 a tablespoon (a measuring spoon) is 6g (it might vary slightly from brand to brand based on how fluffy) .

1 Like
#171

For cooking purposes, a teaspoonful is defined as 5 mL.

An international metric tablespoon is exactly 15 mL, about 0.53 imperial fluid ounce or 0.51 US fluid ounc

2 Likes
#172

Yes, I use a normal silverware sized spoon. Not a soup spoon.

1 Like
#173

Because i didn’t know how much one should be taking until this thread… The bottle’s instructions said one a day…

1 Like
#174

I see.
I use bulk supplements powder from Amazon. Lasts a long time and cheap.

2 Likes
#175

I just got a bulk pack in (1kg/2.2lbs) from amazon. you’re right, it is inexpensive.

1 Like
#176

I take taurine but have lowered the dose to ~2,000 mg/day because two 2025 papers directly challenge the foundational claims underlying the taurine geroprotective case.

A longitudinal study directly disputes the earlier Yadav/Singh et al. 2023 Science paper, which had found taurine declining with age in humans, mice, and monkeys and shown lifespan extension in mice with supplementation. C&EN

The key findings: in blood samples from humans, monkeys, and mice, including longitudinal data from the Baltimore Longitudinal Study of Aging (ages 26–100), found circulating taurine levels often increased or remained constant with age. Crucially, within-individual differences in taurine levels frequently exceeded age-related changes, and taurine levels were inconsistently associated with health outcomes across age, species, and cohorts. National Institutes of Health. In fact, taurine levels increased as women aged. The researchers concluded that the association between taurine levels and functional health status measures depended heavily on genetics and context. Inside Precision Medicine

A cell-based study, with all its strengths and limitations, found that circulating taurine levels were not associated with aging, muscle mass, strength, power, physical performance, body composition, insulin sensitivity, or mitochondrial function in humans Wiley Online Library. This is a comprehensive null result across exactly the outcomes that made the 2023 paper compelling. They concluded that taurine deficiency is therefore unlikely to be a primary driver of aging in humans, and these findings challenge its utility as a biomarker of aging and functional decline. This study does not rule out potential positive health impacts of taurine supplementation in older adults, especially in individuals with low circulating taurine levels and those with chronic diseases.

These studies warrant a meaningful downgrade of the case for taurine supplementation. The central pillar of the taurine geroprotective case was the Singh et al. finding of age-associated decline with the logic being that supplementation restores a deficient state. If circulating taurine does not reliably decline with age in humans (and may increase in women), the interventional rationale weakens considerably. Some resolution could be had by measuring taurine levels. Has anyone done that and do intelligent benchmarks exist?

3 Likes
#177

Whether taurine declines with age is irrelevant. The question is whether supplementing taurine provides any benefit

10 Likes
#178

Exactly… does it benefit?

My N=1 tested, says YES!

Going from a T score 4-years ago showing osteopenia… to a normal T score 2 years ago… after 1 full-year of daily taurine and now this year 2026… even deeper into normal T score… still daily spoonful of taurine in my morning coffee.

Glad I started.

2 Likes
#179

I had titrated from1 to 2 to 3 grams. Experienced itching chest, upper arms. Somehow found study that said Taurine can cause itching. Went back to 1 gram and no more itching.

I must be very sensitive to some of these sides: had experienced ankle swelling and read that lithium (orotate) can cause it. Had moved up to 5 mg a day. Cut back to 5 mg a couple of times a week, and edema has resolved.

1 Like
#180

Edema can also be a side effect of Rapamycin.

3 Likes
#181

A good friend of mine found that taurine upset his digestive track, so he discontinued taking it. Was only taking 2 g per day. It seems that some people have sensitivities to the supplement version. The same friend can down a steak and has no issues.

2 Likes
#182

My mother also has gastrointestinal issues with Taurine. It is a thing.

2 Likes
#183

https://www.sciencedirect.com/science/article/pii/S0753332226004300

Taurine inhibits apolipoprotein E4 aggregation

Highlights

• Impact of taurine on ApoE revealed through simulations, biophysical assays, and cerebral organoid models.

• Taurine inhibits ApoE4 aggregation, mimicking the protective effects of tramiprosate and its metabolite 3-sulfopropanoic acid.

• Taurine shifts ApoE4 phenotype toward the less harmful ApoE3 profile in cerebral organoids.

5 Likes
#184

What is/was recommended daily dosage?

2 Likes
#186

Taurine: The Energy-Drink Amino Acid That Quiets Inflamed Blood Vessels — But Won’t Touch Your Blood Sugar

An 8-week Iranian randomized controlled trial gave 120 type 2 diabetics either 3 g/day of taurine or a starch placebo, both on top of a mild calorie-restricted diet. Taurine did not move the headline glycemic needles — fasting glucose, HbA1c, and lipids were statistically unchanged versus placebo — but it did significantly lower circulating insulin and insulin resistance (HOMA-IR), and produced consistent reductions across a panel of inflammation, oxidative-stress, and endothelial-adhesion markers (hs-CRP, TNF, MDA, ICAM-1, VCAM, E-selectin, MMP-9), while raising total antioxidant capacity. The authors frame this as the first clinical trial linking taurine to endothelial-dysfunction biomarkers in T2DM. The effect sizes are moderate, the study is short, and the biomarker data contain several internal inconsistencies that temper enthusiasm.

Taurine — the sulfur-containing amino acid best known as an energy-drink additive and a hot topic in aging research since a 2023 Science paper linked its decline to mammalian aging — has been put to a modest clinical test in people with type 2 diabetes. The result is a study of contrasts: taurine appears to calm the “vascular weather” of diabetes without meaningfully changing the disease’s defining feature, high blood sugar.

Researchers at Kermanshah University of Medical Sciences in Iran randomized 120 patients to 1 gram of taurine three times daily, or an identical-looking starch placebo, for eight weeks. Everyone also followed a 500-kcal/day deficit diet, meaning taurine’s effects sit on top of a background of gentle weight loss — a design choice that muddies interpretation, since caloric restriction alone improves most of these markers.

The clearest signal was in the endothelium, the single-cell lining of blood vessels that becomes dysfunctional early in diabetes and drives later heart attacks and strokes. Taurine reduced the “stickiness” molecules that let immune cells latch onto and inflame vessel walls — ICAM-1, VCAM, and E-selectin — alongside MMP-9, an enzyme that degrades vascular structure. Markers of oxidative stress (MDA) and inflammation (hs-CRP, TNF) fell, and antioxidant capacity rose. Taurine also cut circulating insulin and improved insulin resistance, suggesting the pancreas was working less hard.

Yet the metabolic story stops there. Fasting glucose, HbA1c, and every lipid fraction showed no significant advantage over placebo. The authors offer a reasonable defense for HbA1c — eight weeks is shorter than the ~120-day lifespan of a red blood cell, so the marker simply hadn’t had time to reflect any change. But the flat fasting glucose is harder to wave away and undercuts any claim that taurine is a glycemic agent.

The bigger picture is mechanistic plausibility meeting messy execution. Taurine’s biology — scavenging reactive oxygen species, neutralizing hypochlorous acid via taurine chloramine, supporting endothelial nitric oxide — makes vascular benefit believable. But this is a single, short, biomarker-only trial from one center, with no functional vascular endpoint (the authors admit they never measured flow-mediated dilation) and no clinical outcomes. It is a promising hypothesis-generator, not a practice-changer.

Actionable Insights (with effect-size magnitudes)

For a scientifically literate self-experimenter, the honest take-home is that **3 g/day taurine is a low-risk, low-cost vascular-and-inflammation intervention with moderate biomarker effects, but not a glucose-lowering tool.**Extracting standardized effect sizes (Cohen’s d, computed from end-of-study group means/SDs) puts the magnitudes in perspective:

  • hs-CRP reduction: d ≈ 0.67 (moderate) — arguably the most translationally meaningful, given CRP’s link to CV risk.
  • Serum insulin: d ≈ 0.64 (moderate).
  • TNF: d ≈ 0.57; ICAM-1: d ≈ 0.57 (moderate).
  • TAC (antioxidant capacity): d ≈ 0.45; HOMA-IR: d ≈ 0.41 (small-to-moderate).
  • MDA: d ≈ 0.36 (small).
  • Glycemic markers you might have hoped for: FBG d ≈ 0.37 but non-significant; HbA1c d ≈ 0.21 (trivial).

Practical framing: these are the magnitudes you’d expect from a supportive nutraceutical, not a drug. Taurine at this dose (well within the EFSA-cited safe ceiling of ~3000 mg/day) is a defensible adjunct if your goal is inflammation/endothelial support. It is not a substitute for anything moving your glucose. The vascular benefits are also confounded by concurrent calorie restriction, so real-world magnitude in a weight-stable person is likely smaller than these numbers.

Context / Source

9 Likes